In recent months, institutional investors, such as hedge funds, have either increased or decreased their stakes in the company, depending on the path they choose to take. Analysts on the sell side anticipate that Stericycle will report earnings of 2.01 cents per share for the current fiscal year. Compared to the previous year, the expansion rate in the company’s sales was 1.1% higher. The company made a profit per share of $0.67 during the same period the year before. The revenue for the quarter came in at $679.80 million, which was higher than the $678.27 million that analysts had anticipated the quarter to bring in. The return on equity for Stericycle was satisfactory, coming in at 6.22%, but the company’s net margin was unfavorable, coming in at 3.28%. The provider of business services reported earnings per share (EPS) for the quarter of $0.48, which is $0.05 higher than the average estimate of $0.43 that analysts gave. On August 5th, the most recent quarterly earnings report that was made public for Stericycle (NASDAQ: SRCL) was made available. Previously, the company had been given a rating of “hold.”ĭeposit $100 and get a $110 to trade stocks
In a report that was released on Friday, the analysts at changed their previous recommendation of “hold” for Stericycle (NASDAQ: SRCL) to a “buy” recommendation.
0 kommentar(er)
